Skip to main content
Research project

M Cragg Roche CD32B regulating modulation of anti-CD20 mAbs

  • Lead researcher:
  • Research funder:
    F. Hoffmann-La Roche Ltd
  • Status:
    Not active


Lead researcher

Professor Mark Cragg

Professor in Experimental Cancer Biology

Research interests

  • Antibody biology
  • Antibody engineering
  • Cancer Immunotherapy
Connect with Mark

Research outputs